| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GBT | Global Blood Therapeutics, Inc. | CATHERS BRIAN EDWIN | Chief Scientific Officer | Mar 01, 2021 | Option Exercise | $44.48 | 1,297 | 57,691 | 12,005 | Mar 03, 2021, 08:00 PM | |
| GBT | Global Blood Therapeutics, Inc. | CATHERS BRIAN EDWIN | Chief Scientific Officer | Feb 01, 2021 | Option Exercise | $47.95 | 1,445 | 69,292 | 9,552 | Feb 03, 2021, 06:28 PM | |
| GBT | Global Blood Therapeutics, Inc. | CATHERS BRIAN EDWIN | Chief Scientific Officer | Sep 01, 2020 | Option Exercise | $60.45 | 1,551 | 93,758 | 7,443 | Sep 03, 2020, 06:34 PM | |
| GBT | Global Blood Therapeutics, Inc. | CATHERS BRIAN EDWIN | Chief Scientific Officer | Aug 20, 2020 | Sale | $63.77 | 2,200 | 140,294 | 5,244 | Aug 24, 2020, 05:14 PM | |
| GBT | Global Blood Therapeutics, Inc. | CATHERS BRIAN EDWIN | Chief Scientific Officer | Jul 31, 2020 | Option Exercise | $41.17 | 290 | 11,939 | 5,469 | Aug 04, 2020, 09:34 PM | |
| GBT | Global Blood Therapeutics, Inc. | CATHERS BRIAN EDWIN | Chief Scientific Officer | Aug 01, 2020 | Option Exercise | $67.48 | 1,045 | 70,517 | 7,444 | Aug 04, 2020, 09:34 PM | |
| GBT | Global Blood Therapeutics, Inc. | CATHERS BRIAN EDWIN | Chief Scientific Officer | Mar 01, 2020 | Option Exercise | $63.96 | 2,594 | 165,912 | 5,179 | Mar 04, 2020, 08:48 PM | |
| GBT | Global Blood Therapeutics, Inc. | CATHERS BRIAN EDWIN | Chief Scientific Officer | Jan 31, 2020 | Option Exercise | $41.17 | 273 | 11,239 | 273 | Feb 04, 2020, 08:50 PM |
Menu